BillTrack50 logo
Free Signup Login
Bill

Bill > H1509

FL H1509

FL H1509
Prescription Drugs

summary

Introduced
03/06/2023
In Committee
04/25/2023
Crossed Over
Passed
Dead
05/05/2023

Introduced Session

2023 Regular Session

Bill Summary

Requires drug manufacturers to notify DBPR of reportable drug price increases; prohibits manufacturers from claiming public records exemption for trade secrets for information provided in forms or reports; requires DFS to designate employee as primary contact on issues relating to PBMs; provides penalty for persons who do not hold certificate of authority to act as administrator; requires PBMs to identify ownership affiliations to office; provides requirements for contracts between PBM & participating pharmacy; provides for biennial examinations of PBMs.

AI Summary

This bill, the Prescription Drug Reform Act, requires drug manufacturers to notify the Department of Business and Professional Regulation (DBPR) of reportable drug price increases, prohibits manufacturers from claiming public records exemption for trade secrets, and requires the Department of Financial Services (DFS) to designate an employee as the primary contact for consumers and pharmacies on issues relating to pharmacy benefit managers (PBMs). The bill also provides penalties for persons who do not hold a certificate of authority to act as an administrator, requires PBMs to identify ownership affiliations, provides requirements for contracts between PBMs and participating pharmacies, and requires biennial examinations of PBMs by the Office of Insurance Regulation.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (25)

Other Sponsors (3)

Appropriations Committee (House), Health & Human Services Committee (House), Healthcare Regulation Subcommittee (House)

Last Action

Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30) (on 05/01/2023)
(2 Companion Bills)

bill text

bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://www.flsenate.gov/Session/Bill/2023/1509
Analysis - Healthcare Regulation Subcommittee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509z.HRS.PDF
BillText https://www.flsenate.gov/Session/Bill/2023/1509/BillText/c3/PDF
Analysis - Health & Human Services Committee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509f.HHS.PDF
Analysis - Health & Human Services Committee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509e.HHS.PDF
BillText https://www.flsenate.gov/Session/Bill/2023/1509/BillText/c2/PDF
Analysis - Appropriations Committee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509d.APC.PDF
Analysis - Appropriations Committee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509c.APC.PDF
BillText https://www.flsenate.gov/Session/Bill/2023/1509/BillText/c1/PDF
Analysis - Healthcare Regulation Subcommittee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509b.HRS.PDF
https://www.flsenate.gov/Session/Bill/2023/1509/Amendment/622887/PDF
Withdrawn Prior to Consideration https://www.flsenate.gov/Session/Bill/2023/1509/Amendment/430279/PDF
Analysis - Healthcare Regulation Subcommittee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509a.HRS.PDF
Analysis - Healthcare Regulation Subcommittee (Post-Meeting) https://www.flsenate.gov/Session/Bill/2023/1509/Analyses/h1509.HRS.PDF
BillText https://www.flsenate.gov/Session/Bill/2023/1509/BillText/Filed/PDF
Loading...